The clonality of the BAP1 mutation, which has been associated with poor prognosis and a high metastasizing potential [21] supports BAP1 as a molecular marker for ccRCC sub-classification [21]. The gene discussed is BAP1; the disease is nonpapillary renal cell carcinoma.